Delving into the Latest Updates on Yew Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Cardiovascular Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

主要研究目的：探索注射用海参糖胺聚糖改善急性缺血性脑卒中瘀血阻络证mRS评分的有效性。次要研究目的：在急性缺血性脑卒中患者中评估给予注射用海参糖胺聚糖是否可以改善神经功能缺损，改善日常生活活动能力，降低卒中复发率。

[Translation]

The main purpose of the study is to explore the effectiveness of sea cucumber glycosaminoglycan injection in improving the mRS score of blood stasis and obstruction syndrome in acute ischemic stroke. The secondary purpose of the study is to evaluate whether sea cucumber glycosaminoglycan injection can improve neurological deficits, improve daily living activities, and reduce stroke recurrence rate in patients with acute ischemic stroke.

Start Date13 May 2020

Sponsor / Collaborator

Yew Pharmaceutical Co. Ltd.

[+2]

100 Clinical Results associated with Yew Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Yew Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Yew Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Yew Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data